中国介入心脏病学杂志2024,Vol.32Issue(3) :168-171.DOI:10.3969/j.issn.1004-8812.2024.03.008

MemoSorb?生物可降解封堵器卵圆孔未闭封堵术后近期疗效观察1例

Observation of the short-term effect of the MemoSorb? biodegradable occluder for the treatment of patient with patent foramen ovale after interventional treatment:a case report

李爱敏 何建新 张迎 黎思 邹育海 顾晓龙
中国介入心脏病学杂志2024,Vol.32Issue(3) :168-171.DOI:10.3969/j.issn.1004-8812.2024.03.008

MemoSorb?生物可降解封堵器卵圆孔未闭封堵术后近期疗效观察1例

Observation of the short-term effect of the MemoSorb? biodegradable occluder for the treatment of patient with patent foramen ovale after interventional treatment:a case report

李爱敏 1何建新 1张迎 2黎思 1邹育海 1顾晓龙1
扫码查看

作者信息

  • 1. 中国人民解放军南部战区总医院心血管内科,广东广州 510030
  • 2. 中国人民解放军南部战区总医院超声诊断科,广东广州 510030
  • 折叠

摘要

卵圆孔未闭(PFO)是不明原因脑卒中的主要致病因素之一,与单纯抗血小板治疗相比,PFO封堵术联合抗血小板治疗能降低PFO导致脑卒中的发生/复发风险.然而,传统PFO封堵器具有自身局限性,生物可降解PFO封堵器的探索应用成为近年先天性心脏病介入治疗领域的热点,国内少有文献报道.中国人民解放军南部战区总医院近期应用MemoSorb®生物可降解PFO封堵器置入1例并进行了术后短期随访,无不良心血管事件发生,该病例报道可为国内PFO的生物可降解介入治疗提供参考.

Abstract

Patent foramen ovale(PFO)is one of the major pathogenic factors of unexplained stroke.Compared with antiplatelet therapy alone,PFO occlusion combined with antiplatelet therapy can reduce the risk of PFO-related stroke occurrence/recurrence.However,the traditional PFO occluder has limitations,and the exploration and application of biodegradable PFO occluder has become a hot spot in the field of interventional therapy for congenital heart disease in recent years.One case was recently implanted with MemoSorb® biodegradable patent foramina ovale occluder in our hospital to provide reference for degradable interventional therapy of PFO.

关键词

卵圆孔未闭/封堵/生物可降解

Key words

Patent foramen ovale/Closure/Biodegradable

引用本文复制引用

基金项目

广州市科技计划(202002020036)

出版年

2024
中国介入心脏病学杂志
北京大学

中国介入心脏病学杂志

CSTPCDCSCD
影响因子:1.224
ISSN:1004-8812
参考文献量16
段落导航相关论文